about
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in humanThe Emerging Role of miRNAs in HTLV-1 Infection and ATLL PathogenesisControversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia.Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemiaTherapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemiaEffect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro.Adult T-cell lymphoma/leukemia presenting as isolated central nervous system T-cell lymphoma.Combination of arsenic and interferon-α inhibits expression of KSHV latent transcripts and synergistically improves survival of mice with primary effusion lymphomasEmodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1The dark side of T memory stem cells.IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphomaPersistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha.Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasmsProapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway.Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphoma.Human T cell lymphotropic virus-associated leukemia/lymphomaRetargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell LeukemiaHuman RNA "rumor" viruses: the search for novel human retroviruses in chronic diseaseRelationship between triterpenoid anticancer drug resistance, autophagy, and caspase-1 in adult T-cell leukemia.Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication.Adult T-cell leukaemia/lymphoma.Treatment of adult T-cell leukemia/lymphoma: past, present, and future.The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking.Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.Impact of the SCF signaling pathway on leukemia stem cell-mediated ATL initiation and progression in an HBZ transgenic mouse model.Adult T-cell leukemia/lymphoma treatment in Bahia, Brazil.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Newer developments in adult T-cell leukemia/lymphoma therapeutics.Animal models on HTLV-1 and related viruses: what did we learn?"Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).Autophagy is associated with cucurbitacin D-induced apoptosis in human T cell leukemia cells.Adult T-cell leukemia/lymphoma in the Middle East: first report of two cases from Lebanon.Myelopathy and adult T-cell leukemia associated with HTLV-1 in a young patient with hearing loss as the initial manifestation of disease.Bortezomib suppresses the growth of leukemia cells with Notch1 overexpression in vivo and in vitro.Apoptosis induction through proteasome inhibitory activity of cucurbitacin D in human T-cell leukemia.
P2860
Q21245197-7DD60725-CF82-4C3B-97BA-C0F3A27EC944Q26800055-3F81C0EB-16D6-4DB2-8857-63C7BEF7D80AQ26852683-4BE42622-5622-45B9-B04B-03C0C4B7F7F2Q33247311-8B418BFC-B934-4E4B-9C07-CF9052FD087BQ33407197-F4C70A95-DE2E-470E-B0B6-3D2C87855927Q33779830-10A326DA-E022-4A1C-A79A-E2560B440C03Q33828073-8CE2BE66-074D-47A4-A7D5-838F42FFB0A0Q34420787-BD4EE1C2-AD26-4EEB-A91C-D5E8E2CE3C07Q34707606-19B12642-8B63-4D67-9960-B1D11439D852Q34837626-8A7918F4-34AA-4AC1-84FD-85BD565E34F6Q35046691-DF6C1E6C-6369-4BAB-A4ED-5CCE7BAB8DE5Q35628873-FAB5AB92-5DE3-4BCB-8B89-02F8CB605D89Q35692386-B2ABE956-F4EB-4718-A2E8-462B5052C9EAQ35750929-65D94125-93C3-4BA6-BFEC-DE256F44F128Q35849897-4B998863-AA0E-4713-A7D8-F472421C0507Q35994968-FA44AFBD-7834-4200-B3CB-83BC7E413EB1Q36020893-FDE0041B-3CC5-457B-8CA5-0E2E46C4E9F0Q36104480-2B8CC06D-605D-4998-9C6A-D12799C9B58BQ36206416-43751DB8-680A-496E-93DF-38EA73D95C19Q36225607-4586AD4D-DDB4-4227-AA4F-F57BF906C35EQ36281149-0E49697B-8874-4692-A26D-D1C2C7704386Q36497719-F931B0B6-E92B-4813-9B03-50DE9EFD1157Q36905364-C77FB207-04FE-438E-946D-4A432A046EC3Q36932981-DA37B4B9-8A08-4126-9D6D-C7963E9D1BCCQ37016509-4399FA6F-CDEA-4446-9ADE-9A73085B234BQ37032793-5249CB24-27AA-43E2-B767-E6B3C9FB454EQ37116770-6DE5CC1C-5565-4D6F-8D25-8DB985CB7C7FQ37152235-B4F255BE-E2DB-4A5C-AE88-C6F3339C6E00Q37331991-68F87ED5-4C69-40A0-8023-6DE593064DBAQ37588235-C63795DD-6279-463D-B812-E3E98C469ED1Q37683306-BFE06E13-C71C-424C-9DBC-167EF24832F2Q37863688-C2871530-C920-42ED-BEE6-947F9AD9309DQ37864326-7CC73DF0-CA98-4DF2-A5EE-AC572DD3B975Q38050763-11512740-73DE-4E3F-9291-34CBCB100F2EQ38055062-2D995863-8CAC-40B7-983B-8DCE2668702DQ38791177-D1366349-55F0-4319-826D-7F4296886E8BQ38910366-FBB6DE37-B339-4474-9314-5A0A631D9C4BQ39028233-E40C8F19-0ABB-4035-A717-BDFF915C4059Q39274612-53A8D30D-CB61-4B09-8056-9140FC2EFCC9Q39527930-A2BE3AA4-A89E-4CA7-8FE7-22BF3CF21A18
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
New therapeutic approaches for adult T-cell leukaemia.
@ast
New therapeutic approaches for adult T-cell leukaemia.
@en
type
label
New therapeutic approaches for adult T-cell leukaemia.
@ast
New therapeutic approaches for adult T-cell leukaemia.
@en
prefLabel
New therapeutic approaches for adult T-cell leukaemia.
@ast
New therapeutic approaches for adult T-cell leukaemia.
@en
P2093
P50
P1433
P1476
New therapeutic approaches for adult T-cell leukaemia.
@en
P2093
David Ghez
Marwan E El-Sabban
Rihab Nasr
P304
P356
10.1016/S1470-2045(04)01608-0
P577
2004-11-01T00:00:00Z